Palisade Asset Management LLC lifted its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 235,958 shares of the pharmacy operator’s stock after purchasing an additional 4,405 shares during the period. Walgreens Boots Alliance comprises 2.4% of Palisade Asset Management LLC’s investment portfolio, making the stock its 9th largest holding. Palisade Asset Management LLC’s holdings in Walgreens Boots Alliance were worth $16,123,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in the company. Cornerstone Advisors Inc. raised its position in shares of Walgreens Boots Alliance by 102.4% during the third quarter. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 214 shares during the period. BlueMountain Capital Management LLC acquired a new position in shares of Walgreens Boots Alliance during the second quarter worth approximately $103,000. Asset Dedication LLC raised its position in shares of Walgreens Boots Alliance by 204.6% during the third quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock worth $115,000 after purchasing an additional 1,060 shares during the period. Ipswich Investment Management Co. Inc. acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $121,000. Finally, Capital Advisors Ltd. LLC raised its position in shares of Walgreens Boots Alliance by 1,150.3% during the third quarter. Capital Advisors Ltd. LLC now owns 2,063 shares of the pharmacy operator’s stock worth $150,000 after purchasing an additional 1,898 shares during the period. Institutional investors own 62.95% of the company’s stock.
Several equities research analysts recently issued reports on WBA shares. Zacks Investment Research downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Monday, December 3rd. BidaskClub downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, January 2nd. Robert W. Baird upped their price target on Walgreens Boots Alliance from $69.00 to $71.00 and gave the stock a “neutral” rating in a report on Friday, October 12th. UBS Group started coverage on Walgreens Boots Alliance in a report on Thursday. They set a “sell” rating and a $70.00 price target for the company. Finally, Pivotal Research upped their price target on Walgreens Boots Alliance from $60.00 to $72.00 and gave the stock a “hold” rating in a report on Monday, October 15th. Four research analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $78.83.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, December 20th. The pharmacy operator reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.43 by $0.03. The company had revenue of $33.79 billion during the quarter, compared to the consensus estimate of $33.90 billion. Walgreens Boots Alliance had a return on equity of 22.17% and a net margin of 3.96%. The firm’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.28 EPS. On average, equities analysts forecast that Walgreens Boots Alliance Inc will post 6.52 EPS for the current fiscal year.
In other news, Director Nancy M. Schlichting sold 7,050 shares of the stock in a transaction on Tuesday, November 20th. The stock was sold at an average price of $78.81, for a total transaction of $555,610.50. Following the completion of the transaction, the director now owns 5,709 shares in the company, valued at approximately $449,926.29. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction on Thursday, November 1st. The stock was sold at an average price of $79.48, for a total value of $217,457.28. Following the transaction, the director now owns 8,207 shares of the company’s stock, valued at approximately $652,292.36. The disclosure for this sale can be found here. Insiders have sold a total of 73,756 shares of company stock valued at $5,824,194 in the last quarter. 15.73% of the stock is owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: “Palisade Asset Management LLC Grows Stake in Walgreens Boots Alliance Inc (WBA)” was first published by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.com-unik.info/2019/01/18/palisade-asset-management-llc-grows-stake-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Read More: What is the quiet period?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.